Saumya Roy

Person

Bangalore, IN

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,145,927
- Issue date Nov 19, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,059,420
- Issue date Aug 13, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted bicyclic compounds useful as T cell activators
- Patent number 11,964,973
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridopyrimidinonyl compounds useful as T cell activators
- Patent number 11,584,747
- Issue date Feb 21, 2023
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,253,525
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 10,959,986
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
- Patent number 10,399,932
- Issue date Sep 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
- Patent number 10,399,933
- Issue date Sep 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IDO inhibitors
- Patent number 10,167,254
- Issue date Jan 1, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IDO inhibitors
- Patent number 9,790,169
- Issue date Oct 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20240400563
- Publication date Dec 5, 2024
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS AS EIF4E INHIBITORS AND THE USES THEREOF
- Publication number 20240246918
- Publication date Jul 25, 2024
- Ribometrix, Inc.
- Rajeev BHIDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR
- Publication number 20240108654
- Publication date Apr 4, 2024
- Juno Therapeutics, Inc.
- David G. KUGLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230151007
- Publication date May 18, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS
- Publication number 20230089255
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Susan WEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210355113
- Publication date Nov 18, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210299126
- Publication date Sep 30, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210188845
- Publication date Jun 24, 2021
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210061802
- Publication date Mar 4, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200069646
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200069695
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
- Publication number 20180079712
- Publication date Mar 22, 2018
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
- Publication number 20180072660
- Publication date Mar 15, 2018
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IDO INHIBITORS
- Publication number 20170231999
- Publication date Aug 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDO INHIBITORS
- Publication number 20160289171
- Publication date Oct 6, 2016
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Substituted bicyclic compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Substituted pyridopyrimidinonyl compounds useful as T cell activators

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

IDO inhibitors

IDO inhibitors

Patents Applicationslast 30 patents

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMPOUNDS AND COMPOSITIONS AS EIF4E INHIBITORS AND THE USES THEREOF

COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

IDO INHIBITORS

IDO INHIBITORS